Global Anti-Infective Medications Market Growth 2025-2031
The global Anti-Infective Medications market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Anti-Infective Medications Industry Forecast” looks at past sales and reviews total world Anti-Infective Medications sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Infective Medications sales for 2025 through 2031. With Anti-Infective Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infective Medications industry.
This Insight Report provides a comprehensive analysis of the global Anti-Infective Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infective Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Infective Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infective Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infective Medications.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infective Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-Infective Medications market?
What factors are driving Anti-Infective Medications market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Infective Medications market opportunities vary by end market size?
How does Anti-Infective Medications break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Anti-Infective Medications Industry Forecast” looks at past sales and reviews total world Anti-Infective Medications sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Infective Medications sales for 2025 through 2031. With Anti-Infective Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infective Medications industry.
This Insight Report provides a comprehensive analysis of the global Anti-Infective Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infective Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Infective Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infective Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infective Medications.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infective Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Antivirals
- Antibacterials
- Antifungals
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Astellas Pharma
- Bayer
- Bristol-Myers Squibb
- Daiichi Sankyo
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Roche
What is the 10-year outlook for the global Anti-Infective Medications market?
What factors are driving Anti-Infective Medications market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Infective Medications market opportunities vary by end market size?
How does Anti-Infective Medications break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Infective Medications Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Infective Medications by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Infective Medications by Country/Region, 2020, 2024 & 2031
2.2 Anti-Infective Medications Segment by Type
2.2.1 Antivirals
2.2.2 Antibacterials
2.2.3 Antifungals
2.3 Anti-Infective Medications Sales by Type
2.3.1 Global Anti-Infective Medications Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Infective Medications Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Infective Medications Sale Price by Type (2020-2025)
2.4 Anti-Infective Medications Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Anti-Infective Medications Sales by Application
2.5.1 Global Anti-Infective Medications Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Infective Medications Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Infective Medications Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Infective Medications Breakdown Data by Company
3.1.1 Global Anti-Infective Medications Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Infective Medications Sales Market Share by Company (2020-2025)
3.2 Global Anti-Infective Medications Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Infective Medications Revenue by Company (2020-2025)
3.2.2 Global Anti-Infective Medications Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Infective Medications Sale Price by Company
3.4 Key Manufacturers Anti-Infective Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infective Medications Product Location Distribution
3.4.2 Players Anti-Infective Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIVE MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Anti-Infective Medications Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Infective Medications Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Infective Medications Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Infective Medications Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Infective Medications Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Infective Medications Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Infective Medications Sales Growth
4.4 APAC Anti-Infective Medications Sales Growth
4.5 Europe Anti-Infective Medications Sales Growth
4.6 Middle East & Africa Anti-Infective Medications Sales Growth
5 AMERICAS
5.1 Americas Anti-Infective Medications Sales by Country
5.1.1 Americas Anti-Infective Medications Sales by Country (2020-2025)
5.1.2 Americas Anti-Infective Medications Revenue by Country (2020-2025)
5.2 Americas Anti-Infective Medications Sales by Type (2020-2025)
5.3 Americas Anti-Infective Medications Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infective Medications Sales by Region
6.1.1 APAC Anti-Infective Medications Sales by Region (2020-2025)
6.1.2 APAC Anti-Infective Medications Revenue by Region (2020-2025)
6.2 APAC Anti-Infective Medications Sales by Type (2020-2025)
6.3 APAC Anti-Infective Medications Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Infective Medications by Country
7.1.1 Europe Anti-Infective Medications Sales by Country (2020-2025)
7.1.2 Europe Anti-Infective Medications Revenue by Country (2020-2025)
7.2 Europe Anti-Infective Medications Sales by Type (2020-2025)
7.3 Europe Anti-Infective Medications Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Infective Medications by Country
8.1.1 Middle East & Africa Anti-Infective Medications Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Infective Medications Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Infective Medications Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Infective Medications Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infective Medications
10.3 Manufacturing Process Analysis of Anti-Infective Medications
10.4 Industry Chain Structure of Anti-Infective Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infective Medications Distributors
11.3 Anti-Infective Medications Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIVE MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Anti-Infective Medications Market Size Forecast by Region
12.1.1 Global Anti-Infective Medications Forecast by Region (2026-2031)
12.1.2 Global Anti-Infective Medications Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Infective Medications Forecast by Type (2026-2031)
12.7 Global Anti-Infective Medications Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Anti-Infective Medications Product Portfolios and Specifications
13.1.3 Abbott Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Astellas Pharma
13.2.1 Astellas Pharma Company Information
13.2.2 Astellas Pharma Anti-Infective Medications Product Portfolios and Specifications
13.2.3 Astellas Pharma Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Astellas Pharma Main Business Overview
13.2.5 Astellas Pharma Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Anti-Infective Medications Product Portfolios and Specifications
13.3.3 Bayer Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Anti-Infective Medications Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Anti-Infective Medications Product Portfolios and Specifications
13.5.3 Daiichi Sankyo Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Information
13.6.2 GlaxoSmithKline Anti-Infective Medications Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GlaxoSmithKline Main Business Overview
13.6.5 GlaxoSmithKline Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Anti-Infective Medications Product Portfolios and Specifications
13.7.3 Merck Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Anti-Infective Medications Product Portfolios and Specifications
13.8.3 Novartis Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Anti-Infective Medications Product Portfolios and Specifications
13.9.3 Pfizer Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Roche
13.10.1 Roche Company Information
13.10.2 Roche Anti-Infective Medications Product Portfolios and Specifications
13.10.3 Roche Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Roche Main Business Overview
13.10.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Infective Medications Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Infective Medications by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Infective Medications by Country/Region, 2020, 2024 & 2031
2.2 Anti-Infective Medications Segment by Type
2.2.1 Antivirals
2.2.2 Antibacterials
2.2.3 Antifungals
2.3 Anti-Infective Medications Sales by Type
2.3.1 Global Anti-Infective Medications Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Infective Medications Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Infective Medications Sale Price by Type (2020-2025)
2.4 Anti-Infective Medications Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Anti-Infective Medications Sales by Application
2.5.1 Global Anti-Infective Medications Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Infective Medications Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Infective Medications Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Infective Medications Breakdown Data by Company
3.1.1 Global Anti-Infective Medications Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Infective Medications Sales Market Share by Company (2020-2025)
3.2 Global Anti-Infective Medications Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Infective Medications Revenue by Company (2020-2025)
3.2.2 Global Anti-Infective Medications Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Infective Medications Sale Price by Company
3.4 Key Manufacturers Anti-Infective Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infective Medications Product Location Distribution
3.4.2 Players Anti-Infective Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIVE MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Anti-Infective Medications Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Infective Medications Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Infective Medications Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Infective Medications Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Infective Medications Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Infective Medications Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Infective Medications Sales Growth
4.4 APAC Anti-Infective Medications Sales Growth
4.5 Europe Anti-Infective Medications Sales Growth
4.6 Middle East & Africa Anti-Infective Medications Sales Growth
5 AMERICAS
5.1 Americas Anti-Infective Medications Sales by Country
5.1.1 Americas Anti-Infective Medications Sales by Country (2020-2025)
5.1.2 Americas Anti-Infective Medications Revenue by Country (2020-2025)
5.2 Americas Anti-Infective Medications Sales by Type (2020-2025)
5.3 Americas Anti-Infective Medications Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infective Medications Sales by Region
6.1.1 APAC Anti-Infective Medications Sales by Region (2020-2025)
6.1.2 APAC Anti-Infective Medications Revenue by Region (2020-2025)
6.2 APAC Anti-Infective Medications Sales by Type (2020-2025)
6.3 APAC Anti-Infective Medications Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Infective Medications by Country
7.1.1 Europe Anti-Infective Medications Sales by Country (2020-2025)
7.1.2 Europe Anti-Infective Medications Revenue by Country (2020-2025)
7.2 Europe Anti-Infective Medications Sales by Type (2020-2025)
7.3 Europe Anti-Infective Medications Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Infective Medications by Country
8.1.1 Middle East & Africa Anti-Infective Medications Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Infective Medications Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Infective Medications Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Infective Medications Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infective Medications
10.3 Manufacturing Process Analysis of Anti-Infective Medications
10.4 Industry Chain Structure of Anti-Infective Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infective Medications Distributors
11.3 Anti-Infective Medications Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIVE MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Anti-Infective Medications Market Size Forecast by Region
12.1.1 Global Anti-Infective Medications Forecast by Region (2026-2031)
12.1.2 Global Anti-Infective Medications Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Infective Medications Forecast by Type (2026-2031)
12.7 Global Anti-Infective Medications Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Anti-Infective Medications Product Portfolios and Specifications
13.1.3 Abbott Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Astellas Pharma
13.2.1 Astellas Pharma Company Information
13.2.2 Astellas Pharma Anti-Infective Medications Product Portfolios and Specifications
13.2.3 Astellas Pharma Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Astellas Pharma Main Business Overview
13.2.5 Astellas Pharma Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Anti-Infective Medications Product Portfolios and Specifications
13.3.3 Bayer Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Anti-Infective Medications Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Anti-Infective Medications Product Portfolios and Specifications
13.5.3 Daiichi Sankyo Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Information
13.6.2 GlaxoSmithKline Anti-Infective Medications Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GlaxoSmithKline Main Business Overview
13.6.5 GlaxoSmithKline Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Anti-Infective Medications Product Portfolios and Specifications
13.7.3 Merck Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Anti-Infective Medications Product Portfolios and Specifications
13.8.3 Novartis Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Anti-Infective Medications Product Portfolios and Specifications
13.9.3 Pfizer Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Roche
13.10.1 Roche Company Information
13.10.2 Roche Anti-Infective Medications Product Portfolios and Specifications
13.10.3 Roche Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Roche Main Business Overview
13.10.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-Infective Medications Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Infective Medications Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antivirals
Table 4. Major Players of Antibacterials
Table 5. Major Players of Antifungals
Table 6. Global Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 7. Global Anti-Infective Medications Sales Market Share by Type (2020-2025)
Table 8. Global Anti-Infective Medications Revenue by Type (2020-2025) & ($ million)
Table 9. Global Anti-Infective Medications Revenue Market Share by Type (2020-2025)
Table 10. Global Anti-Infective Medications Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Anti-Infective Medications Sale by Application (2020-2025) & (K Units)
Table 12. Global Anti-Infective Medications Sale Market Share by Application (2020-2025)
Table 13. Global Anti-Infective Medications Revenue by Application (2020-2025) & ($ million)
Table 14. Global Anti-Infective Medications Revenue Market Share by Application (2020-2025)
Table 15. Global Anti-Infective Medications Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Anti-Infective Medications Sales by Company (2020-2025) & (K Units)
Table 17. Global Anti-Infective Medications Sales Market Share by Company (2020-2025)
Table 18. Global Anti-Infective Medications Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Anti-Infective Medications Revenue Market Share by Company (2020-2025)
Table 20. Global Anti-Infective Medications Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Anti-Infective Medications Producing Area Distribution and Sales Area
Table 22. Players Anti-Infective Medications Products Offered
Table 23. Anti-Infective Medications Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Anti-Infective Medications Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Anti-Infective Medications Sales Market Share Geographic Region (2020-2025)
Table 28. Global Anti-Infective Medications Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Anti-Infective Medications Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Anti-Infective Medications Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Anti-Infective Medications Sales Market Share by Country/Region (2020-2025)
Table 32. Global Anti-Infective Medications Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Anti-Infective Medications Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Anti-Infective Medications Sales by Country (2020-2025) & (K Units)
Table 35. Americas Anti-Infective Medications Sales Market Share by Country (2020-2025)
Table 36. Americas Anti-Infective Medications Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 38. Americas Anti-Infective Medications Sales by Application (2020-2025) & (K Units)
Table 39. APAC Anti-Infective Medications Sales by Region (2020-2025) & (K Units)
Table 40. APAC Anti-Infective Medications Sales Market Share by Region (2020-2025)
Table 41. APAC Anti-Infective Medications Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 43. APAC Anti-Infective Medications Sales by Application (2020-2025) & (K Units)
Table 44. Europe Anti-Infective Medications Sales by Country (2020-2025) & (K Units)
Table 45. Europe Anti-Infective Medications Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 47. Europe Anti-Infective Medications Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Anti-Infective Medications Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-Infective Medications Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Anti-Infective Medications Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Anti-Infective Medications
Table 53. Key Market Challenges & Risks of Anti-Infective Medications
Table 54. Key Industry Trends of Anti-Infective Medications
Table 55. Anti-Infective Medications Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Anti-Infective Medications Distributors List
Table 58. Anti-Infective Medications Customer List
Table 59. Global Anti-Infective Medications Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Anti-Infective Medications Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Anti-Infective Medications Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Anti-Infective Medications Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Anti-Infective Medications Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Anti-Infective Medications Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Anti-Infective Medications Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Anti-Infective Medications Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Anti-Infective Medications Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Anti-Infective Medications Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Anti-Infective Medications Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Anti-Infective Medications Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Anti-Infective Medications Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Anti-Infective Medications Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Abbott Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 74. Abbott Anti-Infective Medications Product Portfolios and Specifications
Table 75. Abbott Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Abbott Main Business
Table 77. Abbott Latest Developments
Table 78. Astellas Pharma Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 79. Astellas Pharma Anti-Infective Medications Product Portfolios and Specifications
Table 80. Astellas Pharma Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Astellas Pharma Main Business
Table 82. Astellas Pharma Latest Developments
Table 83. Bayer Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Anti-Infective Medications Product Portfolios and Specifications
Table 85. Bayer Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Bristol-Myers Squibb Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 89. Bristol-Myers Squibb Anti-Infective Medications Product Portfolios and Specifications
Table 90. Bristol-Myers Squibb Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Bristol-Myers Squibb Main Business
Table 92. Bristol-Myers Squibb Latest Developments
Table 93. Daiichi Sankyo Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 94. Daiichi Sankyo Anti-Infective Medications Product Portfolios and Specifications
Table 95. Daiichi Sankyo Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Daiichi Sankyo Main Business
Table 97. Daiichi Sankyo Latest Developments
Table 98. GlaxoSmithKline Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 99. GlaxoSmithKline Anti-Infective Medications Product Portfolios and Specifications
Table 100. GlaxoSmithKline Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. Merck Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Anti-Infective Medications Product Portfolios and Specifications
Table 105. Merck Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Novartis Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 109. Novartis Anti-Infective Medications Product Portfolios and Specifications
Table 110. Novartis Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Novartis Main Business
Table 112. Novartis Latest Developments
Table 113. Pfizer Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Anti-Infective Medications Product Portfolios and Specifications
Table 115. Pfizer Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. Roche Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 119. Roche Anti-Infective Medications Product Portfolios and Specifications
Table 120. Roche Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Roche Main Business
Table 122. Roche Latest Developments
Table 1. Anti-Infective Medications Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Infective Medications Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antivirals
Table 4. Major Players of Antibacterials
Table 5. Major Players of Antifungals
Table 6. Global Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 7. Global Anti-Infective Medications Sales Market Share by Type (2020-2025)
Table 8. Global Anti-Infective Medications Revenue by Type (2020-2025) & ($ million)
Table 9. Global Anti-Infective Medications Revenue Market Share by Type (2020-2025)
Table 10. Global Anti-Infective Medications Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Anti-Infective Medications Sale by Application (2020-2025) & (K Units)
Table 12. Global Anti-Infective Medications Sale Market Share by Application (2020-2025)
Table 13. Global Anti-Infective Medications Revenue by Application (2020-2025) & ($ million)
Table 14. Global Anti-Infective Medications Revenue Market Share by Application (2020-2025)
Table 15. Global Anti-Infective Medications Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Anti-Infective Medications Sales by Company (2020-2025) & (K Units)
Table 17. Global Anti-Infective Medications Sales Market Share by Company (2020-2025)
Table 18. Global Anti-Infective Medications Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Anti-Infective Medications Revenue Market Share by Company (2020-2025)
Table 20. Global Anti-Infective Medications Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Anti-Infective Medications Producing Area Distribution and Sales Area
Table 22. Players Anti-Infective Medications Products Offered
Table 23. Anti-Infective Medications Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Anti-Infective Medications Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Anti-Infective Medications Sales Market Share Geographic Region (2020-2025)
Table 28. Global Anti-Infective Medications Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Anti-Infective Medications Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Anti-Infective Medications Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Anti-Infective Medications Sales Market Share by Country/Region (2020-2025)
Table 32. Global Anti-Infective Medications Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Anti-Infective Medications Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Anti-Infective Medications Sales by Country (2020-2025) & (K Units)
Table 35. Americas Anti-Infective Medications Sales Market Share by Country (2020-2025)
Table 36. Americas Anti-Infective Medications Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 38. Americas Anti-Infective Medications Sales by Application (2020-2025) & (K Units)
Table 39. APAC Anti-Infective Medications Sales by Region (2020-2025) & (K Units)
Table 40. APAC Anti-Infective Medications Sales Market Share by Region (2020-2025)
Table 41. APAC Anti-Infective Medications Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 43. APAC Anti-Infective Medications Sales by Application (2020-2025) & (K Units)
Table 44. Europe Anti-Infective Medications Sales by Country (2020-2025) & (K Units)
Table 45. Europe Anti-Infective Medications Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 47. Europe Anti-Infective Medications Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Anti-Infective Medications Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-Infective Medications Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Anti-Infective Medications Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Anti-Infective Medications Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Anti-Infective Medications
Table 53. Key Market Challenges & Risks of Anti-Infective Medications
Table 54. Key Industry Trends of Anti-Infective Medications
Table 55. Anti-Infective Medications Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Anti-Infective Medications Distributors List
Table 58. Anti-Infective Medications Customer List
Table 59. Global Anti-Infective Medications Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Anti-Infective Medications Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Anti-Infective Medications Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Anti-Infective Medications Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Anti-Infective Medications Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Anti-Infective Medications Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Anti-Infective Medications Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Anti-Infective Medications Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Anti-Infective Medications Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Anti-Infective Medications Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Anti-Infective Medications Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Anti-Infective Medications Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Anti-Infective Medications Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Anti-Infective Medications Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Abbott Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 74. Abbott Anti-Infective Medications Product Portfolios and Specifications
Table 75. Abbott Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Abbott Main Business
Table 77. Abbott Latest Developments
Table 78. Astellas Pharma Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 79. Astellas Pharma Anti-Infective Medications Product Portfolios and Specifications
Table 80. Astellas Pharma Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Astellas Pharma Main Business
Table 82. Astellas Pharma Latest Developments
Table 83. Bayer Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Anti-Infective Medications Product Portfolios and Specifications
Table 85. Bayer Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Bristol-Myers Squibb Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 89. Bristol-Myers Squibb Anti-Infective Medications Product Portfolios and Specifications
Table 90. Bristol-Myers Squibb Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Bristol-Myers Squibb Main Business
Table 92. Bristol-Myers Squibb Latest Developments
Table 93. Daiichi Sankyo Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 94. Daiichi Sankyo Anti-Infective Medications Product Portfolios and Specifications
Table 95. Daiichi Sankyo Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Daiichi Sankyo Main Business
Table 97. Daiichi Sankyo Latest Developments
Table 98. GlaxoSmithKline Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 99. GlaxoSmithKline Anti-Infective Medications Product Portfolios and Specifications
Table 100. GlaxoSmithKline Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. Merck Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Anti-Infective Medications Product Portfolios and Specifications
Table 105. Merck Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Novartis Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 109. Novartis Anti-Infective Medications Product Portfolios and Specifications
Table 110. Novartis Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Novartis Main Business
Table 112. Novartis Latest Developments
Table 113. Pfizer Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Anti-Infective Medications Product Portfolios and Specifications
Table 115. Pfizer Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. Roche Basic Information, Anti-Infective Medications Manufacturing Base, Sales Area and Its Competitors
Table 119. Roche Anti-Infective Medications Product Portfolios and Specifications
Table 120. Roche Anti-Infective Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Roche Main Business
Table 122. Roche Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-Infective Medications
Figure 2. Anti-Infective Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Infective Medications Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-Infective Medications Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Infective Medications Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Infective Medications Sales Market Share by Country/Region (2024)
Figure 10. Anti-Infective Medications Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Antivirals
Figure 12. Product Picture of Antibacterials
Figure 13. Product Picture of Antifungals
Figure 14. Global Anti-Infective Medications Sales Market Share by Type in 2025
Figure 15. Global Anti-Infective Medications Revenue Market Share by Type (2020-2025)
Figure 16. Anti-Infective Medications Consumed in Hospital Pharmacies
Figure 17. Global Anti-Infective Medications Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 18. Anti-Infective Medications Consumed in Online Pharmacies
Figure 19. Global Anti-Infective Medications Market: Online Pharmacies (2020-2025) & (K Units)
Figure 20. Anti-Infective Medications Consumed in Retail Pharmacies
Figure 21. Global Anti-Infective Medications Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 22. Global Anti-Infective Medications Sale Market Share by Application (2024)
Figure 23. Global Anti-Infective Medications Revenue Market Share by Application in 2025
Figure 24. Anti-Infective Medications Sales by Company in 2025 (K Units)
Figure 25. Global Anti-Infective Medications Sales Market Share by Company in 2025
Figure 26. Anti-Infective Medications Revenue by Company in 2025 ($ millions)
Figure 27. Global Anti-Infective Medications Revenue Market Share by Company in 2025
Figure 28. Global Anti-Infective Medications Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Anti-Infective Medications Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Anti-Infective Medications Sales 2020-2025 (K Units)
Figure 31. Americas Anti-Infective Medications Revenue 2020-2025 ($ millions)
Figure 32. APAC Anti-Infective Medications Sales 2020-2025 (K Units)
Figure 33. APAC Anti-Infective Medications Revenue 2020-2025 ($ millions)
Figure 34. Europe Anti-Infective Medications Sales 2020-2025 (K Units)
Figure 35. Europe Anti-Infective Medications Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Anti-Infective Medications Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Anti-Infective Medications Revenue 2020-2025 ($ millions)
Figure 38. Americas Anti-Infective Medications Sales Market Share by Country in 2025
Figure 39. Americas Anti-Infective Medications Revenue Market Share by Country (2020-2025)
Figure 40. Americas Anti-Infective Medications Sales Market Share by Type (2020-2025)
Figure 41. Americas Anti-Infective Medications Sales Market Share by Application (2020-2025)
Figure 42. United States Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Anti-Infective Medications Sales Market Share by Region in 2025
Figure 47. APAC Anti-Infective Medications Revenue Market Share by Region (2020-2025)
Figure 48. APAC Anti-Infective Medications Sales Market Share by Type (2020-2025)
Figure 49. APAC Anti-Infective Medications Sales Market Share by Application (2020-2025)
Figure 50. China Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 54. India Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Anti-Infective Medications Sales Market Share by Country in 2025
Figure 58. Europe Anti-Infective Medications Revenue Market Share by Country (2020-2025)
Figure 59. Europe Anti-Infective Medications Sales Market Share by Type (2020-2025)
Figure 60. Europe Anti-Infective Medications Sales Market Share by Application (2020-2025)
Figure 61. Germany Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 62. France Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Anti-Infective Medications Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Anti-Infective Medications Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Anti-Infective Medications Sales Market Share by Application (2020-2025)
Figure 69. Egypt Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Anti-Infective Medications in 2025
Figure 75. Manufacturing Process Analysis of Anti-Infective Medications
Figure 76. Industry Chain Structure of Anti-Infective Medications
Figure 77. Channels of Distribution
Figure 78. Global Anti-Infective Medications Sales Market Forecast by Region (2026-2031)
Figure 79. Global Anti-Infective Medications Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Anti-Infective Medications Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Anti-Infective Medications Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Anti-Infective Medications Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Anti-Infective Medications Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Anti-Infective Medications
Figure 2. Anti-Infective Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Infective Medications Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-Infective Medications Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Infective Medications Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Infective Medications Sales Market Share by Country/Region (2024)
Figure 10. Anti-Infective Medications Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Antivirals
Figure 12. Product Picture of Antibacterials
Figure 13. Product Picture of Antifungals
Figure 14. Global Anti-Infective Medications Sales Market Share by Type in 2025
Figure 15. Global Anti-Infective Medications Revenue Market Share by Type (2020-2025)
Figure 16. Anti-Infective Medications Consumed in Hospital Pharmacies
Figure 17. Global Anti-Infective Medications Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 18. Anti-Infective Medications Consumed in Online Pharmacies
Figure 19. Global Anti-Infective Medications Market: Online Pharmacies (2020-2025) & (K Units)
Figure 20. Anti-Infective Medications Consumed in Retail Pharmacies
Figure 21. Global Anti-Infective Medications Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 22. Global Anti-Infective Medications Sale Market Share by Application (2024)
Figure 23. Global Anti-Infective Medications Revenue Market Share by Application in 2025
Figure 24. Anti-Infective Medications Sales by Company in 2025 (K Units)
Figure 25. Global Anti-Infective Medications Sales Market Share by Company in 2025
Figure 26. Anti-Infective Medications Revenue by Company in 2025 ($ millions)
Figure 27. Global Anti-Infective Medications Revenue Market Share by Company in 2025
Figure 28. Global Anti-Infective Medications Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Anti-Infective Medications Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Anti-Infective Medications Sales 2020-2025 (K Units)
Figure 31. Americas Anti-Infective Medications Revenue 2020-2025 ($ millions)
Figure 32. APAC Anti-Infective Medications Sales 2020-2025 (K Units)
Figure 33. APAC Anti-Infective Medications Revenue 2020-2025 ($ millions)
Figure 34. Europe Anti-Infective Medications Sales 2020-2025 (K Units)
Figure 35. Europe Anti-Infective Medications Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Anti-Infective Medications Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Anti-Infective Medications Revenue 2020-2025 ($ millions)
Figure 38. Americas Anti-Infective Medications Sales Market Share by Country in 2025
Figure 39. Americas Anti-Infective Medications Revenue Market Share by Country (2020-2025)
Figure 40. Americas Anti-Infective Medications Sales Market Share by Type (2020-2025)
Figure 41. Americas Anti-Infective Medications Sales Market Share by Application (2020-2025)
Figure 42. United States Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Anti-Infective Medications Sales Market Share by Region in 2025
Figure 47. APAC Anti-Infective Medications Revenue Market Share by Region (2020-2025)
Figure 48. APAC Anti-Infective Medications Sales Market Share by Type (2020-2025)
Figure 49. APAC Anti-Infective Medications Sales Market Share by Application (2020-2025)
Figure 50. China Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 54. India Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Anti-Infective Medications Sales Market Share by Country in 2025
Figure 58. Europe Anti-Infective Medications Revenue Market Share by Country (2020-2025)
Figure 59. Europe Anti-Infective Medications Sales Market Share by Type (2020-2025)
Figure 60. Europe Anti-Infective Medications Sales Market Share by Application (2020-2025)
Figure 61. Germany Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 62. France Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Anti-Infective Medications Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Anti-Infective Medications Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Anti-Infective Medications Sales Market Share by Application (2020-2025)
Figure 69. Egypt Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Anti-Infective Medications Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Anti-Infective Medications in 2025
Figure 75. Manufacturing Process Analysis of Anti-Infective Medications
Figure 76. Industry Chain Structure of Anti-Infective Medications
Figure 77. Channels of Distribution
Figure 78. Global Anti-Infective Medications Sales Market Forecast by Region (2026-2031)
Figure 79. Global Anti-Infective Medications Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Anti-Infective Medications Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Anti-Infective Medications Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Anti-Infective Medications Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Anti-Infective Medications Revenue Market Share Forecast by Application (2026-2031)
